[The diagnostic procedure in pancreatic diseases]

Current clinical practice requires precise diagnostic differentiation in pancreatic conditions. While acute pancreatitis can be initially diagnosed, distinguishing between edematous and necrotizing forms remains a challenge. Chronic pancreatitis severity assessment often relies on invasive procedures like ERCP. Functional impairment and peripancreatic spread are typically evaluated using imaging modalities. Pancreatic carcinoma detection is often delayed until advanced stages, limiting early intervention options. Prior research has shown that imaging and biomarkers improve diagnostic accuracy. However, no prior work had resolved how to integrate these methods effectively in clinical workflows. This gap motivated the need to clarify the role of each diagnostic tool in disease progression. Establishing a clear sequence of investigations remains a critical unmet need in pancreatic diagnostics.

This analysis aims to clarify the sequential use of imaging and invasive diagnostic methods in pancreatic disease management. The specific problem addressed is the lack of consensus on diagnostic pathways for acute and chronic pancreatitis and pancreatic carcinoma. The motivation stems from the need to optimize diagnostic accuracy while minimizing unnecessary procedures. The study focuses on how to sequence investigations after initial diagnosis. It also seeks to define the role of each diagnostic modality in disease staging. The goal is to provide a structured diagnostic approach based on clinical data. This includes determining when to use ERCP, contrast-enhanced CT, and tumor marker tests. The study also evaluates the timing and necessity of needle aspiration in infection detection.

The study reviews clinical data to establish diagnostic sequences for pancreatic conditions. It evaluates the use of contrast-enhanced CT in acute pancreatitis staging. ERCP is analyzed for severity assessment in chronic pancreatitis. Ultrasound-guided needle aspiration is examined for infection detection. Tumor marker tests are assessed for pancreatic carcinoma confirmation. The role of imaging in determining peripancreatic spread is reviewed. The study also considers the integration of these methods into clinical workflows. The approach is based on synthesizing evidence from established diagnostic protocols.

Contrast-enhanced CT is recommended for determining necrosis extent in acute pancreatitis. Ultrasound-guided needle aspiration is proposed for early infection detection. ERCP is emphasized for severity assessment in chronic pancreatitis cases. Imaging techniques are used to evaluate functional impairment and peripancreatic spread. Tumor marker tests are suggested as part of a multi-modal approach for carcinoma confirmation. Fine needle aspiration is highlighted for diagnostic reliability in advanced stages. The study suggests a sequential use of these methods based on clinical presentation. The findings align with the need for structured diagnostic pathways in pancreatic disease management.

The authors propose that contrast-enhanced CT should be used to assess necrosis in acute pancreatitis. They suggest ultrasound-guided needle aspiration for early infection detection. ERCP is recommended for chronic pancreatitis severity evaluation. Imaging is emphasized for determining functional impairment and peripancreatic spread. Tumor markers are proposed as part of a multi-modal approach for carcinoma confirmation. The study supports a sequential use of diagnostic tools based on clinical data. The findings suggest that structured diagnostic pathways improve accuracy and reduce unnecessary procedures. The authors conclude that integrating these methods enhances diagnostic reliability in pancreatic disease management.